Cargando…
Kinome-wide CRISPR-Cas9 knockout screens revealed PLK1 as a therapeutic target for osteosarcoma
Osteosarcoma is the most common malignant bone tumor, tending to be aggressive and recurrent. The therapeutic development for treating osteosarcoma has been largely hampered by the lack of effective and specific targets. Using kinome-wide CRISPR-Cas9 knockout screens, we systematically revealed a co...
Autores principales: | Wang, Renxian, Wang, Dingding, Bai, Xueshan, Guo, Jianxun, Xia, Songxia, Cheng, Yuning, Gu, Yani, Wang, Qian, Nie, Jingjun, Chen, Dafu, Liu, Weifeng, Liang, Junbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328921/ https://www.ncbi.nlm.nih.gov/pubmed/37419907 http://dx.doi.org/10.1038/s41420-023-01526-7 |
Ejemplares similares
-
Carboxypeptidase E is a prognostic biomarker co-expressed with osteoblastic genes in osteosarcoma
por: Chen, Dafu, et al.
Publicado: (2023) -
Analysis of Immune Gene Expression Subtypes Reveals Osteosarcoma Immune Heterogeneity
por: Wan, Ben, et al.
Publicado: (2021) -
Systematic screening for potential therapeutic targets in osteosarcoma through a kinome-wide CRISPR-Cas9 library
por: Wu, Yuanzhong, et al.
Publicado: (2020) -
Therapeutic Potential of Circular RNAs in Osteosarcoma
por: Wan, Ben, et al.
Publicado: (2020) -
Generation and Phenotype Identification of PAX4 Gene Knockout Rabbit by CRISPR/Cas9 System
por: Xu, Yuanyuan, et al.
Publicado: (2018)